We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

118 hedge funds and large institutions have $59.7M invested in Sanofi Contingent Value Rights in 2014 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 21 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $57.3M → $59.7M (+$2.43M)

5% less funds holding

Funds holding: 124 → 118 (-6)

33% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 21

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

Holders
118
Holders Change
-6
Holders Change %
-4.84%
% of All Funds
3.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
14
Reduced
21
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WA
Whitebox Advisors
Minnesota
+$2.53M
2
BPGAM
BTG Pactual Global Asset Management
Bermuda
+$388K
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$160K
4
Allianz Asset Management
Allianz Asset Management
Germany
+$89.1K
5
SFM
Sphera Funds Management
Israel
+$33K

Top Sellers

Rank Fund Capital Flow
1
MFP
Michael F. Price
-$1.94M
2
SM
Scoggin Management
New York
-$1M
3
OAM
Oxford Asset Management
United Kingdom
-$904K
4
JGC
J. Goldman & Co
New York
-$200K
5
GI
GAMCO Investors
Connecticut
-$125K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACP
26
Andalusian Capital Partners
Connecticut
$167K – – –
Hudson Bay Capital Management
27
Hudson Bay Capital Management
Connecticut
$153K +$160K +329,400 New
GCIA
28
Gabelli & Co Investment Advisers
New York
$148K +$2.04K +4,200 +1%
GI
29
GAMCO Investors
Connecticut
$141K -$125K -257,000 -46%
DAM
30
Deltec Asset Management
New York
$140K – – –
Capstone Investment Advisors
31
Capstone Investment Advisors
New York
$139K – – –
Goldman Sachs
32
Goldman Sachs
New York
$129K +$31.9K +65,735 +31%
BCM
33
Basso Capital Management
Connecticut
$128K – – –
CCA
34
Catalyst Capital Advisors
New York
$108K – – –
First Eagle Investment Management
35
First Eagle Investment Management
New York
$105K – – –
FRM
36
Fore Research & Management
New York
$89K – – –
YCM
37
Yakira Capital Management
Connecticut
$76K – – –
EEG
38
E.E. Geduld
$70K +$24.3K +50,000 +50%
U
39
UBS
Switzerland
$48K -$225 -463 -0.5%
ZIG
40
Zuckerman Investment Group
Illinois
$48K – – –
PP
41
Paloma Partners
Connecticut
$47K – – –
Wells Fargo
42
Wells Fargo
California
$44K +$13 +26 +0%
OCM
43
Osterweis Capital Management
California
$41K – – –
CAS
44
CTC Alternative Strategies
Illinois
$35.2K – – –
KAM
45
Knightsbridge Asset Management
California
$35K – – –
IRF
46
IBM Retirement Fund
New York
$32K – – –
ACA
47
Anchor Capital Advisors
Massachusetts
$28K – – –
Morgan Stanley
48
Morgan Stanley
New York
$26K -$113 -232 -0.4%
V
49
Veritable
Delaware
$25K -$175 -360 -0.7%
Korea Investment Corp
50
Korea Investment Corp
South Korea
$23K – – –
1
2
3 4 5

GCVRZ Hedge Fund Activity: Q3 2014 in Review

118 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q3 2014, worth a combined $59.7M — up 4.2% from $57.3M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of GCVRZ and 10 opened new positions — a net loss of 6 holders — while 21 trimmed existing stakes and 14 added.

The largest buyer was Whitebox Advisors, adding an estimated $2.53M. The largest seller was Michael F. Price, cutting an estimated $1.94M.

  • 118 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q3 2014, down from 124 in Q2 2014.
  • Funds reported $59.7M of Sanofi Contingent Value Rights stock for Q3 2014, up 4.2% quarter-over-quarter.
  • 10 funds opened new Sanofi Contingent Value Rights positions in Q3 2014 and 16 closed out, a net change of -6 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q3 2014 was Whitebox Advisors, an estimated $2.53M added.
  • The largest Sanofi Contingent Value Rights seller in Q3 2014 was Michael F. Price, an estimated $1.94M sold.

Based on aggregated 13F filings for Q3 2014.